• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/10

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

10 Cards in this Set

  • Front
  • Back
TB classification:
0, 1, 2, 3, 4, 5
0: no exposure, no infection
1: exposure , no infection
2: infection, no disease
3: infection with disease
4: previous disease
5: disease suspected
Isoniazid
-MOA
-cidal vs. static
-metabolism
-drug interactions
-SE
-inhibits mycolase synthetase (makes cell wall components)
-only cidal in replicating organisms
-hepatic metabolism (slow acetylators have slower metabolism)
-inhibits CYP2C9, induces CYP2E1 (acetominophen metabolites)
-SE: neuropathy (give pyridoxine, also for OD)
-hepatotoxicity ~1%
Rifampin
-inhibits DNA dependent RNA polymerase (binds beta subunit, inhibits transcription)
-SE: rash fever, hepatotoxicity
-induces CYP3A and 2D6 (reduces effect of warfarin, OCs, verapamil, antifungals, antiretrovirals
-uses: TB (w/INH), prophylaxis for H. inf and N. menin, against S. aureus (w/ B-lactams)
-red/orange secretions (along with rifapentine and rifabutin)
Rifampin vs. Rifapentine vs. Rifabutin
-MOA
-half lives
-activity
-cross resistance
-drug interactions
SE
-all same MOA (inhibit DNA dependent RNAp)
-half life: Rifampin (5hrs) < Rifapentine (13hrs) < Rifabutin (45hrs)
-Rifabutin is also active against Mycobacterium avium-intracellulare and used as substitute in TB in HIV infected person on antiHIV meds (instead of rifampin)
-all have cross resistance with eachother
-all induce CYP enzymes (rifampin is strongest)
-SE: rash, orange secretions, neutropenia, leukopenia
Ethambutol
-MOA
-SE
-inhibition of arabinogalactan of cell wall
-SE: optic neuritis (visual acuit and colors), hyperuricemia, rash
-combined with INH and rifampin in TB
Pyrazinamide
-MOA
-SE
-targets fatty acid synthase I gene (mycolic acid synthesis)
-teratogenic, hepatotoxic
Streptomycin
-1st or 2nd line agent?
-what is it?
-MOA
-SE
-second line agent
-aminoglycoside
-inhibits protein synthesis (binds 30S ribosomal unit)
-ototoxic, nephrotoxic, avoid in pregnancy, NMB
Second line agents
1. ototoxic and nephrotoxic
2. use if SM resistant
3. many CNS side effects
4. similar to INH
5. folate antagonist
6. resistant mycobacteria
7. HIV+ pts
1. streptomycin (SM)
2. capreomycin, amikacin
3. cycloserine
4. ethionamide
5. PASA
6. FQs
7. rifabutin
TB regimens
1. PPD+, no disease
2. PPD+, with symptoms
1. 9mo INH
2. 2mo (INH, rifampin, PZA, with ethambutol or SM) + 4mo (INH and rifampin)
When can a TB pt be declared non-infectious?
-no resistant TB
-received 2-3wks multidrug tx
-all close contacts identified
-3 consecutive AFB smears